(FLWS) 1-800 FLOWERS.COM - Overview
Stock: Flowers, Bouquets, Chocolates, Cookies, Gift Baskets
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 71.1% |
| Relative Tail Risk | -14.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.49 |
| Alpha | -66.68 |
| Character TTM | |
|---|---|
| Beta | 1.144 |
| Beta Downside | 1.640 |
| Drawdowns 3y | |
|---|---|
| Max DD | 74.37% |
| CAGR/Max DD | -0.35 |
Description: FLWS 1-800 FLOWERS.COM December 31, 2025
1-800 FLOWERS.COM, Inc. (NASDAQ: FLWS) is a U.S.–based retailer that sells a broad assortment of occasion-driven gifts-including fresh-cut flowers, plants, gourmet food baskets, chocolates, wines, and personalized items-through an online-first platform and a portfolio of branded sites such as 1-800-Flowers.com, Harry & David, and Shari’s Berries. The business is organized into three reporting segments: Consumer Floral & Gifts, Gourmet Foods & Gift Baskets, and BloomNet, its wholesale flower-delivery network.
Key performance indicators (as of FY 2023) show total revenue of roughly **$1.8 billion**, with the Consumer Floral & Gifts segment contributing about 55 % of sales. The company reported an adjusted operating margin of **~5 %**, reflecting modest profitability after investing in same-day logistics and technology upgrades. Subscription-based “Frequent Flora” memberships now represent **≈12 % of recurring revenue**, a growth driver that cushions seasonal volatility.
Sector-level drivers that materially affect FLWS include the continued shift of discretionary gifting from brick-and-mortar to e-commerce (e-commerce penetration in specialty retail rose to **~38 %** in 2023), and macro-economic pressures on consumer spending such as inflation-adjusted disposable income trends. Additionally, supply-chain resilience for perishable goods-particularly the ability to secure fresh-cut flowers from global growers-remains a critical operational risk.
For a deeper dive into FLWS’s valuation metrics and scenario analysis, see the ValueRay profile.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -212.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA -3.52 > 1.0 |
| NWC/Revenue: 5.33% < 20% (prev 9.51%; Δ -4.18% < -1%) |
| CFO/TA -0.01 > 3% & CFO -6.76m > Net Income -212.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.9m) vs 12m ago -0.61% < -2% |
| Gross Margin: 37.63% > 18% (prev 0.39%; Δ 3724 % > 0.5%) |
| Asset Turnover: 156.1% > 50% (prev 154.5%; Δ 1.63% > 0%) |
| Interest Coverage Ratio: -4.93 > 6 (EBITDA TTM -25.4m / Interest Expense TTM 15.9m) |
Altman Z'' 0.55
| A: 0.09 (Total Current Assets 417.3m - Total Current Liabilities 332.8m) / Total Assets 893.1m |
| B: 0.09 (Retained Earnings 82.6m / Total Assets 893.1m) |
| C: -0.08 (EBIT TTM -78.3m / Avg Total Assets 1.02b) |
| D: 0.14 (Book Value of Equity 83.4m / Total Liabilities 603.4m) |
| Altman-Z'' Score: 0.55 = B |
Beneish M -3.47
| DSRI: 1.01 (Receivables 55.7m/61.4m, Revenue 1.59b/1.76b) |
| GMI: 1.05 (GM 37.63% / 39.35%) |
| AQI: 0.70 (AQ_t 0.19 / AQ_t-1 0.27) |
| SGI: 0.90 (Revenue 1.59b / 1.76b) |
| TATA: -0.23 (NI -212.6m - CFO -6.76m) / TA 893.1m) |
| Beneish M-Score: -3.47 (Cap -4..+1) = AA |
What is the price of FLWS shares?
Over the past week, the price has changed by -6.02%, over one month by -1.93%, over three months by +19.06% and over the past year by -49.88%.
Is FLWS a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FLWS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6 | 47.8% |
| Analysts Target Price | 6 | 47.8% |
| ValueRay Target Price | 3.4 | -16.7% |
FLWS Fundamental Data Overview February 01, 2026
P/S = 0.1746
P/B = 0.9531
P/EG = 2.8316
Revenue TTM = 1.59b USD
EBIT TTM = -78.3m USD
EBITDA TTM = -25.4m USD
Long Term Debt = 123.5m USD (from longTermDebt, last quarter)
Short Term Debt = 40.7m USD (from shortTermDebt, last quarter)
Debt = 134.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -59.1m USD (from netDebt column, last quarter)
Enterprise Value = 217.7m USD (276.8m + Debt 134.3m - CCE 193.3m)
Interest Coverage Ratio = -4.93 (Ebit TTM -78.3m / Interest Expense TTM 15.9m)
EV/FCF = -5.51x (Enterprise Value 217.7m / FCF TTM -39.5m)
FCF Yield = -18.14% (FCF TTM -39.5m / Enterprise Value 217.7m)
FCF Margin = -2.49% (FCF TTM -39.5m / Revenue TTM 1.59b)
Net Margin = -13.41% (Net Income TTM -212.6m / Revenue TTM 1.59b)
Gross Margin = 37.63% ((Revenue TTM 1.59b - Cost of Revenue TTM 988.9m) / Revenue TTM)
Gross Margin QoQ = 42.08% (prev 35.67%)
Tobins Q-Ratio = 0.24 (Enterprise Value 217.7m / Total Assets 893.1m)
Interest Expense / Debt = 4.62% (Interest Expense 6.21m / Debt 134.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = -61.8m (EBIT -78.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.25 (Total Current Assets 417.3m / Total Current Liabilities 332.8m)
Debt / Equity = 0.46 (Debt 134.3m / totalStockholderEquity, last quarter 289.7m)
Debt / EBITDA = 2.33 (negative EBITDA) (Net Debt -59.1m / EBITDA -25.4m)
Debt / FCF = 1.50 (negative FCF - burning cash) (Net Debt -59.1m / FCF TTM -39.5m)
Total Stockholder Equity = 273.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -20.93% (Net Income -212.6m / Total Assets 893.1m)
RoE = -77.77% (Net Income TTM -212.6m / Total Stockholder Equity 273.3m)
RoCE = -19.73% (EBIT -78.3m / Capital Employed (Equity 273.3m + L.T.Debt 123.5m))
RoIC = -13.62% (negative operating profit) (NOPAT -61.8m / Invested Capital 454.2m)
WACC = 8.01% (E(276.8m)/V(411.0m) * Re(10.13%) + D(134.3m)/V(411.0m) * Rd(4.62%) * (1-Tc(0.21)))
Discount Rate = 10.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
Fair Price DCF = unknown (Cash Flow -39.5m)
EPS Correlation: 3.52 | EPS CAGR: 41.77% | SUE: 2.26 | # QB: 1
Revenue Correlation: -17.83 | Revenue CAGR: 11.33% | SUE: 0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.80 | Chg30d=-0.263 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-06-30): EPS=-1.07 | Chg30d=-0.163 | Revisions Net=-1 | Growth EPS=-30.5% | Growth Revenue=-10.6%
EPS next Year (2027-06-30): EPS=-0.57 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+46.7% | Growth Revenue=+3.7%